BRENDA CUPP: Open Payments
NPI 1407063282 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 103 payments from 16 companies in 2025. Trend: 2023 $660 · 2024 $1,059 · 2025 $1,496
Food & beverage: $1,496
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $237 |
| Neurocrine BioSciences, Inc. | 18 | $207 |
| Axsome Therapeutics, Inc. | 12 | $176 |
| Vanda Pharmaceuticals Inc. | 10 | $140 |
| E.R. Squibb & Sons, L.L.C. | 12 | $136 |
| Teva Pharmaceuticals USA, Inc. | 6 | $116 |
| Alkermes, Inc. | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Lundbeck LLC | 5 | $89 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
Products named: VRAYLAR, INGREZZA, Auvelity, REXULTI, COBENFY, FANAPT, AUSTEDO XR, ARISTADA.
Industry payments across NC — which companies pay providers there.
